Dr Reddy's Laboratories working on enhancing Covid-19 portfolio

As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator

from Today's Paper https://ift.tt/2XVXJxO